We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$177M
Cap. Flow
+$136M
Cap. Flow %
6.83%
Top 10 Hldgs %
28.11%
Holding
4,203
New
330
Increased
2,288
Reduced
1,042
Closed
109

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.4M
2
NVDA icon
NVIDIA
NVDA
+$6.62M
3
MSFT icon
Microsoft
MSFT
+$5.14M
4
EWC icon
iShares MSCI Canada ETF
EWC
+$4.46M
5
LLY icon
Eli Lilly
LLY
+$4.44M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.05M
2
GE icon
GE Aerospace
GE
+$1.19M
3
LIN icon
Linde
LIN
+$955K
4
K
Kellanova
K
+$804K
5
KMB icon
Kimberly-Clark
KMB
+$781K

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Financials 12.87%
3 Consumer Discretionary 9.03%
4 Healthcare 8.77%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAVN
3476
Navan Inc
NAVN
$7.4B
$427 ﹤0.01%
+25
New +$397
SAIL
3477
SailPoint Inc
SAIL
$10.6B
$425 ﹤0.01%
21
-93
-82% -$1.94K
NTIC icon
3478
Northern Technologies International Corp
NTIC
$80M
$407 ﹤0.01%
52
ACR
3479
ACRES Commercial Realty
ACR
$108M
$405 ﹤0.01%
+19
New +$405
TLSI icon
3480
TriSalus Life Sciences
TLSI
$345M
$405 ﹤0.01%
+58
New +$325
SUSB icon
3481
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
$404 ﹤0.01%
+16
New +$404
ETON icon
3482
Eton Pharmaceutcials
ETON
$1.22B
$389 ﹤0.01%
+23
New +$405
LWAY icon
3483
Lifeway Foods
LWAY
$481M
$388 ﹤0.01%
16
-9
-36% -$221
AMBP icon
3484
Ardagh Metal Packaging
AMBP
$3.01B
$385 ﹤0.01%
+94
New +$357
PRME icon
3485
Prime Medicine
PRME
$559M
$385 ﹤0.01%
+111
New +$494
SBC
3486
SBC Medical Group
SBC
$314M
$375 ﹤0.01%
+87
New +$332
ALH
3487
Alliance Laundry Holdings
ALH
$5.52B
$366 ﹤0.01%
+18
New +$433
NKTX icon
3488
Nkarta
NKTX
$172M
$355 ﹤0.01%
+192
New +$384
AII
3489
American Integrity Insurance
AII
$411M
$354 ﹤0.01%
+17
New +$378
NAMS icon
3490
NewAmsterdam Pharma
NAMS
$3.34B
$351 ﹤0.01%
+10
New +$364
ITRN icon
3491
Ituran Location and Control
ITRN
$1.05B
$344 ﹤0.01%
8
NMAX
3492
Newsmax Inc
NMAX
$1.16B
$340 ﹤0.01%
44
-34
-44% -$327
DLO icon
3493
dLocal
DLO
$4.24B
$339 ﹤0.01%
24
AHL
3494
DELISTED
Aspen Insurance
AHL
$334 ﹤0.01%
+9
New +$332
RYAM icon
3495
Rayonier Advanced Materials
RYAM
$610M
$330 ﹤0.01%
+56
New +$364
IGIC icon
3496
International General Insurance
IGIC
$1.15B
$326 ﹤0.01%
13
HPP
3497
Hudson Pacific Properties
HPP
$779M
$325 ﹤0.01%
+30
New +$445
RCKT icon
3498
Rocket Pharmaceuticals
RCKT
$394M
$319 ﹤0.01%
+91
New +$312
CXDO icon
3499
Crexendo
CXDO
$222M
$317 ﹤0.01%
+49
New +$321
EP icon
3500
Empire Petroleum
EP
$111M
$316 ﹤0.01%
104
-207
-67% -$695

Similar funds

GAMMA Investing's Q4 2025 Portfolio in Review

As of Q4 2025, GAMMA Investing held 4,203 positions worth $1.99B, up 9.8% from $1.81B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GAMMA Investing deployed $136M of net new capital in Q4 2025, opening 330 new positions and adding to 2,288 existing holdings. Its largest new stake was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $2.05M trimmed.

  • GAMMA Investing's largest Q4 2025 buy was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.
  • GAMMA Investing added most to Apple in Q4 2025, an estimated $10.4M increase.
  • GAMMA Investing's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $2.05M.
  • GAMMA Investing fully exited Kellanova in Q4 2025, selling an estimated $804K.
  • GAMMA Investing's ten largest holdings make up 28% of its $1.99B portfolio in Q4 2025.
  • GAMMA Investing opened 330 new positions and closed 109 in Q4 2025.
  • GAMMA Investing's portfolio value rose 9.8% quarter-over-quarter to $1.99B.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.